Medical Management of Women with Breast Cancer

Document Type : Original Article

Authors

1 Biotoxicology Laboratory, Department of Biology, Faculty of Nature and Life Sciences, Djillali Liabés University, BP 89, Sidi Bel Abbes, Algeria.

2 Department of Pathological Anatomy, Faculty of Medicine, Sidi Bel Abbes University Hospital, Sidi Bel Abbes, Algeria

Abstract

Breast cancer in Algeria, like everywhere else in the world, is a major public health problem. For several years, women with breast cancer have benefited from increasingly effective and more and more personalized treatments, the management of which depends on the stage of development of the tumor, its characteristics, age and condition. patient's state of health. Since the 2000s, patients admitted to the pathological anatomy service of the CHU of Sidi bel abbés have been systematically evaluated HER2, in order to recruit those who could benefit from targeted therapy (HerceptinÒ). Comes after the evaluation of the amplification status of this gene by fluorescence in situ hybridization (FISH) of intermediate scores (HER2 score 2). Other markers are evaluated for women with this cancer, for better therapeutic management (hormone receptors, Ki67, etc.), see monitoring in the event of a possible relapse.

Keywords